Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded
- Contract number
- SPE2DR26F9F70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,633
Award facts
- Contract value 100% obligated
- $1,633.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Teriparatide 560mcg/2.24mL pen injections. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 17, 2025. Teriparatide is a recombinant human parathyroid hormone used in the treatment of osteoporosis and bone health conditions, representing part of the company's comprehensive pharmaceutical supply portfolio to military and federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime contractor on this delivery order with no identified subcontractors. As a prominent supplier within the DLA's global pharmaceutical support network, the company demonstrates significant capability in fulfilling federal medical supply requirements across multiple therapeutic domains. The award reflects AmerisourceBergen's established role in supporting Defense Health Agency and military healthcare programs through competitive contract vehicles. The relatively modest order value suggests this is a routine resupply transaction executed under the company's expansive master contract framework that enables flexible and rapid pharmaceutical delivery to federal customers.
Quick answers
Who was awarded contract SPE2DR26F9F70?
SPE2DR26F9F70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F9F70 worth?
The government has obligated $1,633 on SPE2DR26F9F70.
Is contract SPE2DR26F9F70 an order under another contract?
Yes. SPE2DR26F9F70 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9F70 competed?
The extent of competition for SPE2DR26F9F70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award